Trials / Completed
CompletedNCT00378625
Efficacy, Effect on Gametocytes and Tolerability of the Addition of Artesunate to Amodiaquine in Colombia
Randomised, Double Blind Clinical Trial of the Efficacy, Effect on Gametocytes and Tolerability of Amodiaquine Vs Amodiaquine Plus Artesunate in the Treatment of Uncomplicated P. Falciparum Malaria in Quibdo, Colombia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 360 (planned)
- Sponsor
- Centro Internacional de Entrenamiento e Investigaciones Médicas · Academic / Other
- Sex
- All
- Age
- 1 Year – 65 Years
- Healthy volunteers
- Not accepted
Summary
The primary goal of this study is to quantify the benefit of adding artesunate to amodiaquine in treating patients with uncomplicated P. falciparum malaria, in a low transmission area in Colombia. The benefit will be assessed in terms of: * Efficacy * Tolerability * Time of fever clearance * Time of parasite clearance * Proportion of gametocyte carriers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Artesunate |
Timeline
- Start date
- 2000-04-01
- Completion
- 2006-03-01
- First posted
- 2006-09-20
- Last updated
- 2006-09-20
Locations
1 site across 1 country: Colombia
Source: ClinicalTrials.gov record NCT00378625. Inclusion in this directory is not an endorsement.